# Teriparatide for Postsurgical Hypoparathyroidism

> **NCT01171690** · PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 5 (actual)

## Conditions studied

- Hypoparathyroidism Post-surgical

## Interventions

- **DRUG:** Teriparatide

## Key facts

- **NCT ID:** NCT01171690
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Funding problems
- **Last updated:** 2014-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171690, "Teriparatide for Postsurgical Hypoparathyroidism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01171690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*